false
--05-31
0001549084
0001549084
2026-11-16
2026-11-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
November
16, 2026
(Date
of earliest event reported)
CHRONOSCALE
HOLDINGS CORPORATION
(Exact
name of registrant as specified in its charter)
| Nevada |
|
001-37854 |
|
42-3357005 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification
No.) |
| 2440
Sand Hill Road, Suite 400, Menlo Park, CA |
|
94025 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
(650)
977-4969
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.001 per share |
|
CHRN |
|
Nasdaq
Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐
Emerging growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. Entry into a Material Definitive Agreement.
The
Private Placements
On
November 18, 2026, ChronoScale Holdings Corporation, a Nevada corporation (the “Company”), entered into definitive
agreements for two independent, concurrent private placement offerings: (i) a securities purchase agreement (the “Common Stock
Purchase Agreement”) with the purchasers named therein (the “Common Stock Purchasers”) for the private placement (the
“Common Stock Private Placement”) of shares (the “Shares”) of the Company’s common stock, par value $0.001
per share (the “Common Stock”), at a purchase price of $8.00 per Share, and (ii) a preferred equity purchase agreement (the
“PEPA,” and together with the Common Stock Purchase Agreement, the “Purchase Agreements”), with the investor
signatory thereto (the “Investor,” and together with the Common Stock Purchasers, the “Purchasers”) for the private
placement from time to time (the “Preferred Stock Private Placement,” and together with the Common Stock Private Placement,
the “Private Placements”) of up to an aggregate of $500,000,000 (the “Commitment Amount”) of newly designated
Series C Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), subject to certain conditions and
limitations, at a purchase price per share equal to the Stated Value (as defined in Item 5.03 below) divided by 103%. Goldman Sachs &
Co. LLC is serving as exclusive capital markets advisor to the Company and is acting as lead placement agent for the Private
Placements. Northland Capital Markets is acting as co-placement agent for the Private Placements. Lake Street Capital Markets and B.
Riley Securities are serving as senior financial advisors, and Lucid Capital Markets and Needham & Company are serving as financial
advisors, to the Company. The Shares and the shares of Series C Preferred Stock will be sold in two separate Private Placements
in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”).
The Company expects to close on
the transactions under the Common Stock Purchase Agreement on November 18, 2026, and expects to receive $153.0 million in gross proceeds in consideration of approximately 19.1 million shares of Common Stock. The Company expects to deliver an initial put notice to the Investor for the purchase of shares of Series C
Preferred Stock having an aggregate purchase price of $10.0 million on November 18, 2026.
The
Company intends to use the net proceeds from the Common Stock Private Placement to fund its capital commitment to the Partnership (as
defined below), which includes, among other things, the construction and development of a data center project located in Odessa,
Texas (the “Project”) and the purchase of GPUs for deployment at the Project, and for general corporate purposes. The Company
intends to use the net proceeds from the Preferred Stock Private Placement for working capital and general corporate purposes.
Each
Purchase Agreement contains customary representations, warranties and agreements by the Company and the applicable Purchasers, indemnification
obligations of the Company (and, in the case of the PEPA, the Investor) and other obligations of the parties. The representations, warranties
and covenants contained in the Purchase Agreements were made only for purposes of such agreements and as of the dates specified therein;
are solely for the benefit of the parties thereto (except as specifically set forth therein); may be subject to qualifications and limitations
agreed upon by the parties in connection with negotiating such agreements, instead of establishing matters as facts; and may be subject
to standards of materiality applicable to the contracting parties that differ from those applicable to investors generally; and should
not be relied upon as characterizations of the actual state of facts or condition of the Company.
Under
the Common Stock Purchase Agreement, the Company agreed, subject to certain exceptions for exempt issuances, not to issue, enter into
any agreement to issue or announce the issuance of any shares of Common Stock or Common Stock equivalents, or file any registration statement
(other than as contemplated by the Registration Rights Agreement (as defined below)), from the date of the Common Stock Purchase Agreement
until 30 days from the effective date of the Registration Statement (as defined below). In addition, the Company’s directors, officers
and 10% stockholders entered into lock-up agreements with the Placement Agent (the
“Lock-Up Agreements”) restricting transfers of their shares of Common Stock for a period of 30 days from the effective date
of the Registration Statement, subject to customary exceptions.
Common
Stock Private Placement
Under
the Common Stock Purchase Agreement, the Company may not issue Shares in excess of 19.99% of the shares of Common Stock issued and outstanding
immediately prior to the execution of the Common Stock Purchase Agreement (as reduced by any shares issued or issuable in any transaction
that may be aggregated with the Common Stock Private Placement under applicable Nasdaq rules, the “Exchange Cap”) unless
and until the Stockholder Approval (as defined in Item 5.07 below) has become effective in accordance with Rule 14c-2(b) under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”). As described in Item 5.07 below, the Stockholder Approval has been
obtained by the written consent of the holders of a majority of the outstanding voting power of the Company and shall become effective
no earlier than 20 calendar days after the definitive information statement on Schedule 14C (the “Information Statement”) is first
sent or given to the Company’s stockholders pursuant to Rule 14c-2(b) under the Exchange Act.
Preferred
Stock Private Placement
Under
the PEPA, the Company has the right, but not the obligation, to require the Investor to purchase, from time to time during the Commitment
Period (as defined below), an aggregate number of shares of Series C Preferred Stock up to the Commitment Amount, subject to certain
conditions and limitations. The Commitment Period commenced on the date of the PEPA and will terminate on the earliest of (i) November
18, 2030, (ii) the date on which the Investor has purchased shares of Series C Preferred Stock having an aggregate purchase price
equal to the Commitment Amount, and (iii) such time as there ceases to be a sufficient number of authorized but unissued shares
of Common Stock remaining under the PEPA Exchange Cap (as defined below) to permit the Company to deliver a put notice (the “Commitment
Period”). The Company may also terminate the PEPA upon prior written notice to the Investor, provided that there are no outstanding
put notices under which shares of Series C Preferred Stock have yet to be issued.
Unless
waived by the Investor, (i) the aggregate purchase price for each put will be subject to a cap of $50 million, (ii) the Company may effect
no more than one put within any seven calendar day period, and (iii) the aggregate Stated Value of Series C Preferred Stock outstanding
at any one time may not exceed $50 million. There is no mandatory minimum number of puts and no non-usage fee. The Company’s right
to deliver a put notice is subject to the satisfaction of certain conditions, including, among others, (a) the lowest daily volume weighted
average price of the Common Stock for each of the five consecutive trading days prior to the put notice date equaling or exceeding 110%
of the Floor Price (as defined in Item 5.03 below) then in effect; provided, however, if the Floor Price has been reduced in accordance
with the Certificate of Designation (as defined in Item 5.03 below), then, unless the most recent reduction of the Floor Price was agreed
to or ratified by the Investor, at least five trading days shall have elapsed since the most recent reduction of the Floor Price; provided,
further, if the Floor Price or the Ceiling Price (as defined in Item 5.03 below) has been increased in accordance with the Certificate
of Designation, such increase was agreed to or ratified by the Investor, (b) other than with respect to an initial put not in excess
of $10 million, a registration statement covering the resale of the Conversion Shares (as defined below) having been declared and remaining
effective, (c) the Company having filed the Certificate of Designation prior to or concurrently with the delivery of the initial put
notice, (d) the Company not having entered into a definitive agreement to consummate a fundamental transaction and (e) Wesley Cummins
(or a successor acceptable to, or deemed acceptable by, the Investor) serving as the Chairman or Chief Executive Officer of the Company.
The
Company may not sell shares of Series C Preferred Stock under the PEPA to the extent that the aggregate number of shares of Common Stock
issuable upon conversion of all shares of Series C Preferred Stock issued under the PEPA (the “Conversion Shares”), assuming
conversion at the conversion price then in effect, would exceed 19.99% of the shares of Common Stock outstanding as of the date of the
PEPA, as reduced by any shares issued or issuable in any transaction that may be aggregated with the Preferred Stock Private Placement
under applicable Nasdaq rules (the “PEPA Exchange Cap”), to the extent required by such rules. Shares of Common Stock issued
or issuable under the Common Stock Purchase Agreement have priority over the Conversion Shares for purposes of the PEPA Exchange Cap.
Pursuant
to the PEPA, the Company agreed to file a registration statement with the U.S. Securities and Exchange
Commission (“SEC”) covering the resale
of the Conversion Shares issuable in respect of the initial put no later than the 30th calendar day following the date of the PEPA, and
to have such registration statement declared effective no later than the 30th calendar day following such filing deadline (or the 60th
calendar day in the event of a “full review” by the SEC). The Company also agreed to file additional registration statements
or post-effective amendments, as applicable, to register the resale of the Conversion Shares issuable in respect of subsequent puts.
The
summary of the material terms of the Series C Preferred Stock set forth below in Item 5.03 of this Current Report on Form 8-K is incorporated
by reference into this Item 1.01 in its entirety.
Registration
Rights Agreement
In
connection with the Common Stock Private Placement, the Company and the Common Stock Purchasers entered into a registration rights agreement
(the “Registration Rights Agreement”), pursuant to which the Company agreed to file a registration statement with the SEC
to register the resale of the Shares (the “Registration Statement”) no later than the later of (i) the 15th calendar day
following the closing date under the Common Stock Purchase Agreement and (ii) December 10, 2026. The Company also agreed to use its commercially
reasonable efforts to have the Registration Statement declared effective as soon as reasonably practicable after filing, and in any event
no later than the 60th calendar day following such closing date (or the 90th calendar day in the event of a “full review”
by the SEC), and to keep the Registration Statement effective until the earliest of (i) the date that all registrable securities covered
thereby have been sold thereunder, (ii) the date that all registrable securities covered thereby may be sold without restriction pursuant
to Rule 144 under the Securities Act, and (iii) the second anniversary of the date of the Registration Rights Agreement. If the Company
fails to file the Registration Statement by the filing deadline, or if the Registration Statement is not declared effective by the applicable
deadline or ceases to be available for resales (subject to certain exceptions), the Company will be required to pay the Common Stock
Purchasers liquidated damages equal to 1.0% of the aggregate amount invested by each Common Stock Purchaser for each 30-day period of
such failure, subject to an aggregate cap of 8.0% of the aggregate purchase price paid by such Common Stock Purchaser in the Common Stock
Private Placement. The Company also agreed to indemnify the Common Stock Purchasers against certain liabilities, including liabilities
under the Securities Act.
The
Shares were, and the shares of Series C Preferred Stock were and will be, offered and sold, and any Conversion Shares and the Services
Agreement Warrant and the STN Warrant (each as defined below) (and the Services Agreement Warrant Shares and the STN Warrant Shares (each
as defined below)) and any Note Shares (as defined below) will be issued, in reliance on the exemption from registration provided
by Section 4(a)(2) of the Securities Act. The Shares, the shares of Series C Preferred Stock and the Conversion Shares, the Services
Agreement Warrant and the Services Agreement Warrant Shares, the STN Warrant and the STN Warrant Shares and any Note Shares have not
been registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration
or an applicable exemption from registration requirements.
The
foregoing descriptions of the Common Stock Purchase Agreement, the PEPA, the Lock-Up Agreements and the Registration Rights Agreement
do not purport to be complete and are qualified in their entirety by reference to the Common Stock Purchase Agreement (including the
form of Lock-Up Agreement attached as Exhibit B thereto), the PEPA and the Registration Rights Agreement filed as Exhibits 10.1, 10.2
and 10.3, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
STN
Contribution Agreement
On
November 17, 2026, OD1 JV Holdings LLC, a Delaware limited liability company (the “Partnership”), CHRN OD1 Holdings
LLC, a wholly-owned subsidiary of the Company (“ChronoScale Member”), the Company, as guarantor, STN OD1 Holdings LLC (“STN
Member”), an affiliate of STN One Incorporated (“STN”), STN, as guarantor, and RXT Power, LLC, an indirect subsidiary
of STN (the “Sublandlord”), entered into a contribution agreement (the “Contribution Agreement”) relating to
the development of the Project. Pursuant to the Contribution Agreement, at the Contribution Closing (as defined below), STN Member will
contribute, and will cause its affiliates to contribute, to the Partnership (i) the GPU Services Agreement (as defined below) and
certain related contracts, (ii) substantially all other assets, permits, rights and interests of STN and its affiliates used in the development,
construction or operation of the Project, (iii) a leasehold interest in the Project site under a ground sublease from the Sublandlord,
and (iv) a license to certain retained intellectual property and technology of STN and its affiliates, in exchange for 3,900,000 common
units of the Partnership, representing 100% of the outstanding common units of the Partnership immediately following the Contribution
Closing.
The
Company expects all conditions to the closing under the Contribution Agreement to be satisfied or waived, and such closing to occur
on November 18, 2026 (the “Contribution Closing”). The Contribution Closing is subject to customary and other closing
conditions.
Additionally,
at the Contribution Closing, ChronoScale Member will fund a $220 million loan to the Partnership in exchange for an unsecured
convertible promissory note (the “Partnership Convertible Note”), which will automatically convert into common units of the
Partnership upon clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), which
will represent 50% of the outstanding common units of the Partnership immediately following such conversion, as further described below
under “Partnership Convertible Note.”
As
a condition to the Contribution Closing, the Partnership will enter into the Term Loan Agreement (as defined below) with Macquarie
Equipment Capital Inc. (“Macquarie”), under which Macquarie will make a $74,687,500 term loan to the Partnership
(the “Term Loan”), the proceeds of which will be used to repay a portion of the obligations of STN and certain of
its affiliates under their existing credit facility with Macquarie, as further described below under “Term Loan Agreement.”
The
Contribution Agreement contains customary representations, warranties and covenants of the parties, including representations of STN
Member and the Sublandlord regarding the contributed assets, the Project site, and the Project’s power, permits and development
status. The representations, warranties and covenants contained in the Contribution Agreement were made only for purposes of that agreement
and as of the dates specified therein; are solely for the benefit of the parties thereto; may be subject to qualifications and limitations
agreed upon by the parties, including by confidential disclosure schedules, instead of establishing matters as facts; and should not
be relied upon as characterizations of the actual state of facts or condition of the Company or the Partnership.
The
foregoing description of the Contribution Agreement does not purport to be complete and is qualified in its entirety by reference to
the Contribution Agreement, which is filed as Exhibit 10.4 to this Current Report on Form 8-K and incorporated herein by reference.
A&R
LLCA
In
connection with the Contribution Closing, ChronoScale Member and STN Member will enter into an amended and restated limited liability
company agreement of the Partnership (the “A&R LLCA”), which sets forth the following principal terms:
| ● | STN
Member has agreed to make an initial capital contribution of $390 million in exchange for
3,900,000 common units, representing 50% of the common equity of the Partnership. STN Member’s
contribution consists of the GPU Services Agreement, the ground lease for the Project site
and related Project assets having an agreed value of $251,923,177.23, with the balance
payable in cash within 90 days following the closing of project financing for at least 75%
of the project budget (a “Qualified Project Financing”). If no Qualified Project
Financing occurs, STN Member has no obligation to fund such cash balance. ChronoScale Member
has agreed to lend to the Partnership $220,000,000, and in consideration therefor,
the Partnership shall issue and deliver to ChronoScale Member the Partnership Convertible
Note, which shall automatically, and without any further action on the part of the ChronoScale
Member or the Partnership, convert in full on the HSR Clearance Date (as defined below) in
accordance with the terms of the Partnership Convertible Note. |
| ● | Until
a Qualified Project Financing occurs, ChronoScale Member is required to fund such additional
amounts as are necessary to fund the Project, without a specified cap, which amounts are
repayable with interest from STN Member’s deferred cash contribution or, to the
extent insufficient, from distributable cash on a priority basis. Thereafter, the members
may be required to make additional pro rata capital contributions, and a member’s failure
to fund may result in dilution and the loss of certain governance rights. |
| ● | ChronoScale
Member serves as manager of the Partnership, subject to consent rights of STN Member
over specified matters and STN Member’s right to remove the manager upon certain
trigger events, including fraud, gross negligence or willful misconduct in connection with
the Project or bankruptcy. ChronoScale Member is responsible for arranging project financing. |
| ● | Distributable
cash will generally be distributed to the members pro rata, subject to certain priority payments
and a management incentive plan, and to restrictions in any project financing documents. |
| ● | Upon
a change of control of the Company or of STN, the other member may elect to cause the Partnership
to redeem the common units held by the member undergoing the change of control, or to purchase
its own common units, in each case at fair market value. If such repurchase does not close
within a specified period, the electing member may require a sale of the Partnership to a
third party, including through the exercise of drag-along rights. |
The
A&R LLCA also provides for customary governance and management rights, pre-emptive rights, information rights, transfer restrictions,
including a right of first offer, and confidentiality obligations.
The
foregoing description of the A&R LLCA does not purport to be complete and is qualified in its entirety by reference to the A&R
LLCA, which will be filed as Exhibit 10.6 to an amendment to this Current Report on Form 8-K and incorporated herein
by reference.
Partnership
Convertible Note
On
November 18, 2026, in connection with the Contribution Closing and pursuant to the terms
of the Contribution Agreement, the Partnership will issue the Partnership Convertible
Note to ChronoScale Member in an aggregate principal amount of $220 million. $200
million of the proceeds of the Partnership Convertible Note will be paid directly
to Super Micro Computer, Inc. solely to fund the Partnership’s purchase of GPUs and the
remaining $20 million will be funded directly to the Partnership for general corporate purposes.
The
Partnership Convertible Note will bear interest at a fixed rate of 8% per annum, paid in kind monthly, and may not be voluntarily
prepaid by the Partnership. The Partnership Convertible Note will be subordinated in right of payment to the Term Loan, other
than with respect to the payment of interest in kind and the conversion of the Partnership Convertible Note. Upon the expiration or termination
of the applicable waiting period under the HSR Act (the “HSR Clearance Date”), the outstanding principal amount of the Partnership
Convertible Note (excluding capitalized interest) will automatically convert into a number of common units of the Partnership equal to
such principal amount divided by $100.00 per common unit, rounded down to the nearest whole common unit, and all accrued interest will
be cancelled. Unless previously converted, the Partnership Convertible Note will mature on the earliest to occur of (i) the date that
is 91 days after the maturity date of the Term Loan, (ii) the termination of the Contribution Agreement prior to the HSR Clearance Date
and (iii) acceleration of the Partnership Convertible Note pursuant to its terms. Prior to conversion, ChronoScale Member will have
the rights of a member of the Partnership under the A&R LLCA (other than the right to receive distributions), to the extent provided
therein. The Partnership Convertible Note will contain customary representations, warranties and specified covenants and will
set forth customary events of default, including bankruptcy or insolvency events, a deemed liquidation event of the Partnership and certain
defaults under or terminations of material Project agreements, after which the outstanding principal amount of, and any accrued but unpaid
interest on, the Partnership Convertible Note may be declared immediately due and payable.
The
foregoing description of the Partnership Convertible Note does not purport to be complete and is qualified in its entirety by
reference to the Partnership Convertible Note, which will be filed as Exhibit 4.2 to an amendment to this Current
Report on Form 8-K and incorporated herein by reference.
Term Loan Agreement
In
connection with the Contribution Closing, the Partnership, as borrower, will enter into a term loan agreement (the “Term
Loan Agreement”) with Macquarie, as administrative agent and sole lender. Under the Term Loan Agreement, Macquarie will make
a single term loan to the Partnership on the closing date in an aggregate principal amount of $74,687,500, constituting the Term
Loan. The Partnership will use the proceeds of the Term Loan to repay a portion of the outstanding obligations of STN under its
existing term loan agreement with Macquarie and to pay fees and expenses in connection with the transactions. All other obligations under
such credit facility will remain solely obligations of STN and its affiliates. The Term Loan will be non-recourse to the
Company and ChronoScale Member, and neither the Company nor ChronoScale Member will guarantee or provide other credit support
for the Term Loan or the retained portion of the credit facility.
The
Term Loan matures on the date that is 90 days after the closing date, or earlier upon acceleration, and bears interest at a fixed
rate of 10% per annum, computed on the basis of a 360-day year. Interest is paid in kind and is due at maturity. The Partnership may
prepay the Term Loan at any time and must prepay it with the net cash proceeds of certain asset dispositions, debt incurrences and
equity issuances, subject to customary exceptions.
The
obligations under the Term Loan Agreement are guaranteed by the Partnership’s subsidiaries and are secured by a first-priority
security interest in substantially all of the Partnership’s and its subsidiaries’ assets, including the equity interests
in the Partnership’s subsidiaries and the GPUs and related GPU assets deployed at the Project. The Term Loan is non-recourse
to the Company and its subsidiaries (other than the Partnership and its subsidiaries). The Term Loan Agreement contains representations
and warranties, affirmative and negative covenants and events of default customary for financings of this type, including a change of
control event of default if STN and the Company, collectively, cease to own 100% of the equity interests in the Partnership.
The
foregoing description of the Term Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the
Term Loan Agreement, which will be filed as Exhibit 10.7 to an amendment to this Current Report on Form 8-K and
incorporated herein by reference.
GPU
Services Agreement
At
the Contribution Closing, the Partnership will
become the provider under an Amended and Restated GPU Services Agreement (Order #1), including its Terms of Service and related exhibits
and schedules (the “GPU Services Agreement”), with a leading frontier artificial intelligence lab (the “Customer”).
The Partnership will assume the GPU Services Agreement by assignment and novation from STN. Under the GPU Services Agreement,
the Partnership will provide the Customer with dedicated GPU services at the Project, with a service term of approximately six years
for each tranche (subject to extension at the Customer’s option). The GPU services will be made available to the Customer in four
tranches. The GPU Services Agreement also contemplates that, if agreed by the parties in writing, the Partnership may deploy optional
additional tranches of GPU capacity at the Project for the Customer.
The
first tranche is expected to be delivered in the fourth quarter of calendar 2026, and the remaining tranches are expected
to be delivered in the first half of calendar year 2027 (subject to extension in certain circumstances). A substantial portion of the
first phase is backstopped by credit support from an investment-grade technology company, and the GPU Services Agreement is expected
to provide up to $7.5 billion in total contract value to the Partnership over approximately six years, assuming full performance and
delivery of the contracted capacity and excluding any extension periods and the additional tranches.
The
GPU Services Agreement may be terminated by the Customer under certain circumstances, including, with respect to affected tranches, delayed
delivery and sustained service level failures, for which cure rights may be available. The Partnership’s termination rights are
more limited, and neither party may terminate for convenience.
The
GPU Services Agreement also contains other customary provisions for an agreement of this nature, including acceptance testing, service
level commitments, delay discounts, security requirements, representations and warranties, force majeure, indemnities, limitations of
liability, change of control provisions and provisions relating to the financing of the GPU systems.
Services
Agreement Warrant
In
connection with the GPU Services Agreement and its assignment to the Partnership, the Company will issue to the Customer a warrant (the
“Services Agreement Warrant”) to purchase up to 8,072,152 shares of Common Stock (the “Services Agreement Warrant Shares”),
at an exercise price of $0.01 per share. Fifty percent of the Services Agreement Warrant Shares will vest in four equal sub-tranches
upon the delivery and acceptance of each of the four tranches under the GPU Services Agreement, and the remaining fifty percent will
vest upon the Customer entering into a take-or-pay offtake agreement with the Company or one of its subsidiaries for at least 40 MW of
critical IT load at a second site owned by the Company or one of its subsidiaries (an “Expansion Agreement”) and the delivery
to, and acceptance by, the Customer of at least 40 MW of critical IT load from such site. Any unvested portion of the Services Agreement
Warrant will terminate if the GPU Services Agreement or the Expansion Agreement, as applicable, expires or is terminated, or upon a material
payment breach by the Customer that remains uncured for 60 days following written notice, subject to certain exceptions. The Services
Agreement Warrant will expire on the tenth anniversary of its issuance, and any vested portion will be automatically exercised immediately
prior to expiration. The Services Agreement Warrant may be exercised only for cash, may not be exercised to the extent that, after giving
effect to such exercise, the holder (together with its affiliates and certain related parties) would beneficially own in excess of 4.99%
of the outstanding shares of Common Stock (which percentage the holder may waive, or increase or decrease up to 9.99%, upon 61 days’
written notice), and may not be exercised to the extent that the Services Agreement Warrant Shares, together with any shares aggregated
therewith under applicable Nasdaq rules, would exceed 19.9% of the shares of Common Stock outstanding immediately after giving effect
to such exercise (with the shares issued or issuable under the Common Stock Purchase Agreement having priority). Exercise of the Services
Agreement Warrant is also subject to compliance with applicable antitrust laws, including the HSR Act, to the extent applicable. The
Company will be required to file a registration statement covering the resale of the Services Agreement Warrant Shares within 30 days
following the first exercise of the Services Agreement Warrant and to grant the Customer customary piggyback registration rights.
STN
Warrant
In
connection with the Partnership, the Company will issue to STN a warrant (the “STN Warrant”) to purchase up to 850,000 shares
of Common Stock (the “STN Warrant Shares”) at an exercise price of $0.001 per share, subject to customary adjustments. The
STN Warrant Shares will vest in three approximately equal tranches upon the achievement of specified milestones relating to the Project
and certain future data center developments financed by the Company’s subsidiary, and any STN Warrant Shares that have not vested
on or prior to the third anniversary of the issue date will be forfeited. The issuance and vesting of the STN Warrant are subject to
the funding of capital contributions to the Partnership by STN Member. Vested STN Warrant Shares may be exercised, for cash or on a cashless
basis, beginning six months after the issue date and until the fifth anniversary of the issue date (or, if no STN Warrant Shares have
vested by the third anniversary of the issue date, such third anniversary), and the Company may elect to settle any exercise in cash.
The STN Warrant may not be exercised to the extent that, after giving effect to such exercise, the holder (together with its attribution
parties) would beneficially own in excess of 4.99% of the outstanding shares of Common Stock, or to the extent the shares issued under
the STN Warrant, together with any shares aggregated therewith under applicable Nasdaq rules, would exceed 19.99% of the outstanding
shares of Common Stock (with the shares issued or issuable under the Common Stock Purchase Agreement having priority). The STN Warrant
is not transferable, other than in whole together with a permitted transfer of all of the membership interests in the Partnership held
by STN’s affiliate, and STN has agreed not to engage in short sales or hedging transactions with respect to the Common Stock for
three years following the issue date. The foregoing description of the STN Warrant does not purport to be complete and is qualified in
its entirety by reference to the form of STN Warrant, which will be filed as Exhibit 4.1 to an amendment to this Current
Report on Form 8-K and incorporated herein by reference.
STN
Note Assignment
In
connection with the Contribution Closing, the Company
will enter into an assignment and exchange agreement (the “Note Assignment Agreement”) with APLD Intermediate Holdco
LLC (“APLD Intermediate”), an affiliate of Applied Digital Corporation (“APLD”) and APLD ChronoScale HoldCo LLC,
the Company’s controlling stockholders, pursuant to which APLD Intermediate will assign to the Company all of its right, title
and interest in, to and under the Subordinated Promissory Note, dated October 9, 2026, issued by STN One Incorporated to APLD Intermediate in the original principal amount of $30,000,000 (the “STN Note”), in exchange for, at the Company’s
election, either (i) a cash payment equal to the outstanding principal of, and accrued and unpaid interest on, the STN Note as of the
effective date of such assignment or (ii) a number of shares of Common Stock (the “Note Shares”) equal to such amount divided
by $8.00 (the “Note Assignment”). Following the Note Assignment, the Company (directly or through one or more of its
wholly-owned subsidiaries) intends to contribute the STN Note to the Partnership in exchange for equity interests in the Partnership.
Because APLD Intermediate is an affiliate of the Company’s controlling stockholders, the Note Assignment was reviewed and approved
by the APLD Related Party Transactions Committee of the Company’s Board of Directors in accordance with the Company’s related
person transaction policy. To the extent applicable, the issuance of Note Shares will be subject to the effectiveness of the Stockholder
Approval (as defined in Item 5.07 below).
The
foregoing description of the Note Assignment Agreement does not purport to be complete and is qualified in its entirety by reference
to the Note Assignment Agreement, which will be filed as Exhibit 10.5 to an amendment to this Current Report on
Form 8-K and incorporated herein by reference.
Item
2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
Term
Loan and Partnership Convertible Note
The
information set forth in Item 1.01 of this Current Report on Form 8-K under the headings “STN Contribution Agreement,” “Partnership
Convertible Note” and “Term Loan Agreement” is incorporated by reference into this Item 2.03 in their entirety.
Convertible
Note (APLD)
In
connection with the closing of the Common Stock Purchase Agreement,
the Company issued an unsecured convertible promissory note (the “Convertible Note”) payable to APLD, providing for an unsecured
loan in the aggregate principal amount of $97.0 million (the “Principal Amount”), the entire amount of which has been funded.
The Convertible Note was issued in a private placement in reliance on the exemption from registration provided by Section 4(a)(2) of
the Securities Act. The Convertible Note and Convertible Note Shares (as defined below) have not been registered under the Securities
Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from
registration requirements. Because APLD is a controlling stockholder of the Company, the issuance of the Convertible Note was reviewed
and approved by the APLD Related Party Transactions Committee of the Company’s Board of Directors in accordance with the Company’s
related person transaction policy.
The
outstanding Principal Amount will mature on December 31, 2026 (the “Maturity Date”). No interest accrues or is payable
on the Principal Amount, including during the existence of any event of default. The Company may not prepay the Convertible Note, in
whole or in part, prior to the Maturity Date without the prior written consent of APLD.
The
Convertible Note may not be converted into shares of Common Stock prior to the effectiveness of the Stockholder Approval (as defined
in Item 5.07 below). Upon the effectiveness of the Stockholder Approval, the outstanding Principal Amount will automatically convert
into a number of shares of Common Stock (the “Convertible Note Shares”) equal to the Principal Amount divided by $8.00
per share, subject to adjustment for stock splits, combinations and reclassifications. No fractional shares will be issued upon conversion,
and the Company will, at its election, either pay cash in lieu of any fractional share or round up to the next whole share.
The
Convertible Note includes customary representations, warranties, covenants and events of default.
The
foregoing description of the Convertible Note does not purport to be complete and is qualified in its entirety by reference to the form
of Convertible Note, which is filed as Exhibit 4.3 to this Current Report on Form 8-K and incorporated
herein by reference.
Item 3.02. Unregistered Sales of Equity Securities.
The
disclosures set forth in Item 1.01 above with respect to the Shares, the Series C Preferred Stock and the Conversion Shares, the STN
Warrant and the STN Warrant Shares, the Services Agreement Warrant and the Services Agreement Warrant Shares and any Note Shares,
and the disclosures set forth in Item 2.03 above with respect to the Convertible Note and the Convertible Note Shares, are incorporated
in this Item 3.02 by reference.
Item
5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
November 16, 2026, the Company filed with the Secretary of State of the State of Nevada a Certificate of Designations of the Powers,
Preferences and Relative, Participating, Optional and Other Restrictions of Series C Convertible Preferred Stock (the “Certificate
of Designation”), designating 500,000 shares of the Company’s authorized but unissued preferred stock as Series C Preferred
Stock, with a stated value of $1,000 per share (the “Stated Value”). The following is a summary of the principal terms of
the Series C Preferred Stock as set forth in the Certificate of Designation:
Ranking;
Liquidation. The Series C Preferred Stock ranks senior to the Common Stock, on parity with any future class or series of equity securities
that by its terms ranks on parity with the Series C Preferred Stock, junior to any class or series of equity securities that by its terms
ranks senior to the Series C Preferred Stock, and junior to all existing and future indebtedness of the Company. Upon any liquidation,
dissolution or winding up of the Company, holders of the Series C Preferred Stock will be entitled to receive, after payment of the Company’s
debts and other liabilities and before any distribution to holders of Common Stock, an amount per share equal to the Stated Value plus
any accrued but unpaid dividends.
Dividends;
Voting. Holders of the Series C Preferred Stock are entitled to participate, on an as-converted basis (without regard to any limitations
on conversion), in any dividends or distributions paid to holders of Common Stock. The Series C Preferred Stock has no voting rights,
except as required by law and for certain customary protective provisions requiring the consent of the holders of a majority of the outstanding
shares of Series C Preferred Stock.
Conversion.
Each share of Series C Preferred Stock will be convertible at the option of the holder, at any time after the registration statement
registering the shares of Common Stock issuable upon conversion of the Series C Preferred Stock has been declared effective by
the SEC, into a number of shares of Common Stock equal to the Stated Value divided by the conversion price in effect on the conversion
date (the “Conversion Price”). The Conversion Price will equal the greater of (i) 95% of the lowest volume weighted average
price of the Common Stock during the five trading days immediately preceding the conversion date and (ii) the floor price, initially
$12.00 (as may be adjusted from time to time, the “Floor Price”), provided that in no event will the Conversion Price exceed
the ceiling price, initially $25.00 (as may be adjusted from time to time, the “Ceiling Price”). The Company’s Board
of Directors may, in its sole discretion, increase or reduce the Floor Price (but not below $3.60) or the Ceiling Price at any
time.
Conversion
Limitations. A holder may not convert shares of Series C Preferred Stock to the extent that, after giving effect to such conversion,
the holder (together with its attribution parties) would beneficially own in excess of 4.99% of the outstanding shares of Common Stock
(which percentage a holder may increase or decrease upon written notice to the Company, provided that any increase will not be effective
until the 61st day after such notice and in no event may such percentage exceed 9.99%). Conversions are also subject to the PEPA Exchange
Cap. If any holder is prevented from converting any portion of its Series C Preferred Stock because of the PEPA Exchange Cap, and such
limitation continues through the earlier of the date that is 18 months following the issuance of such Series C Preferred Stock and the
date that is 36 months following the date of the PEPA, then such portion will be redeemed by the Company in cash, within ten trading
days after such date, at a price equal to the greater of (A) the product of (x) the Conversion Price in effect on the first date such
limitation prohibited conversion and (y) the number of shares of Common Stock into which such Series C Preferred Stock is convertible
at such Conversion Price (without regard to any limitations on conversion), and (B) 110% of the Stated Value of such Series C Preferred
Stock.
Trading
Failure Redemption. If the Common Stock is suspended from trading on its principal market for ten consecutive trading days or for
more than an aggregate of 20 trading days in any 365-day period, or ceases to be listed on its principal market (a “Trading Failure”),
each holder may require the Company to redeem all or any portion of its Series C Preferred Stock in cash at a price equal to the greater
of (i) the Stated Value of such Series C Preferred Stock and (ii) the product of (x) the lowest Conversion Price in effect during the
period beginning on the date immediately preceding such Trading Failure and ending on the date of the holder’s redemption notice
and (y) the number of shares of Common Stock into which such Series C Preferred Stock is then convertible (without regard to any limitations
on conversion).
Fundamental
Transactions. In connection with certain fundamental transactions, each holder may elect either to convert all of its Series C Preferred
Stock into Common Stock, contingent upon the consummation of such fundamental transaction, or to receive, upon any subsequent conversion,
the alternate consideration receivable in such fundamental transaction by a holder of the number of shares of Common Stock into which
such Series C Preferred Stock was convertible immediately prior thereto.
The
foregoing description of the Series C Preferred Stock does not purport to be complete and is qualified in its entirety by reference to
the Certificate of Designation filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On
November 18, 2026, in connection with the entry into the Purchase Agreements, APLD and APLD ChronoScale HoldCo LLC, the holders
of approximately 95.7% of the voting power of the Company’s outstanding capital stock entitled to vote thereon prior to giving
effect to the transactions described in this Current Report on Form 8-K, approved by written consent in lieu of a meeting, for purposes
of Nasdaq Listing Rule 5635(d), if applicable, the issuance of shares of Common Stock solely to the extent such issuance would exceed
the applicable Exchange Cap (i) pursuant to the Common Stock Purchase Agreement, (ii) upon conversion of the Series C Preferred Stock,
(iii) upon exercise of the STN Warrant, (iv) upon exercise of the Services Agreement Warrant, (v) upon conversion of the Convertible
Note and (vi) as Note Shares pursuant to the Note Assignment Agreement, if any (collectively, the “Stockholder Approval”).
The Company’s Board of Directors unanimously approved the foregoing issuances and recommended that the Company’s stockholders
approve them. The number of votes received pursuant to the written consent is sufficient to approve such issuances, and no further vote
of the Company’s stockholders is required.
The
Stockholder Approval will become effective on the date that is 20 calendar days after the date on which the Information Statement is
first sent or given to the Company’s stockholders in accordance with Rule 14c-2(b) under the Exchange Act.
Item 8.01. Other Matters.
On
November 18, 2026, the Company issued a press release announcing the execution of the Private Placements and the Contribution
Agreement. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein
by reference.
Forward-Looking
Statements
This
Current Report on Form 8-K contains “forward-looking statements” within the meaning of Section 27A of the Securities Act
and Section 21E of the Exchange Act, including statements regarding, among other things, the consummation and timing of the closings
under the Common Stock Purchase Agreement and the PEPA and the delivery of the initial put notice under the PEPA, the Company’s
ability to sell shares of Series C Preferred Stock under the PEPA, the effectiveness of the Stockholder Approval and the mailing of the
Information Statement, the terms of the Series C Preferred Stock, the filing and effectiveness of the Registration Statement and the
registration statement required under the PEPA, the Company’s anticipated use of the net proceeds from the Private Placements,
the consummation and timing of the Contribution Closing and the related transactions, the expiration or termination of the waiting
period under the HSR Act and the conversion of the Partnership Convertible Note, the development of the Project, the delivery of the
remaining tranches and the anticipated total contract value under the GPU Services Agreement, the ability of the Partnership to obtain
a Qualified Project Financing, the vesting and exercise of the Services Agreement Warrant and the STN Warrant, and the consummation of
the Note Assignment. These forward-looking statements are based on the Company’s current assumptions, expectations and beliefs
and are subject to substantial risks, uncertainties, assumptions and changes in circumstances that may cause the Company’s actual
results, performance or achievements to differ materially from those expressed or implied in any forward-looking statement. These risks
include, but are not limited to, the risk that the closings under the Common Stock Purchase Agreement or the PEPA do not occur on
the anticipated timeline or at all, the risk that the conditions to the Company’s right to deliver put notices under the PEPA
are not satisfied or waived on a timely basis or at all, the risk that the waiting period under the HSR Act does not expire or terminate
prior to the maturity of the Partnership Convertible Note, the risk that the Partnership is unable to deliver the remaining tranches
under the GPU Services Agreement on a timely basis or at all, the risk that the Customer exercises its termination rights or that
the Customer does not exercise any of its rights to expand its capacity, the risk that the Partnership is unable to obtain a Qualified
Project Financing on acceptable terms or at all, the Company’s obligation to fund the Project prior to a Qualified Project Financing,
and market risks, trends and conditions. Other factors that may cause the Company’s actual results to differ from those expressed
or implied in the forward-looking statements in this Current Report on Form 8-K are discussed in the Company’s filings with the
SEC, including the “Risk Factors” sections contained therein. Except as required by law, the Company assumes no obligation
to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.
Item
9.01. Financial Statements and Exhibits.
EXHIBIT
INDEX
| Exhibit
No. |
|
Description |
| 3.1 |
|
Certificate of Designations of the Powers, Preferences and Relative, Participating, Optional and Other Restrictions of Series C Convertible Preferred Stock. |
| 4.1@ |
|
Form
of Common Stock Purchase Warrant issued to STN One Incorporated. |
| 4.2@ |
|
Convertible
Promissory Note issued by OD1 JV Holdings LLC to CHRN OD1 Holdings LLC. |
| 4.3 |
|
Form of Unsecured Convertible Promissory Note issued by ChronoScale Holdings Corporation to Applied Digital Corporation. |
| 10.1*** |
|
Form of Common Stock Securities Purchase Agreement. |
| 10.2** |
|
Preferred
Equity Purchase Agreement, dated as of November 18, 2026, by and between ChronoScale Holdings Corporation and the investor
signatory thereto. |
| 10.3** |
|
Form of Registration Rights Agreement. |
| 10.4*** |
|
Contribution Agreement, dated as of November 17, 2026, by and among OD1 JV Holdings LLC and the other parties thereto. |
| 10.5@ |
|
Assignment
and Exchange Agreement by and between ChronoScale Holdings Corporation and APLD Intermediate Holdco
LLC. |
| 10.6@ |
|
Form
of Amended and Restated Limited Liability Company
Agreement of OD1 JV Holdings LLC. |
| 10.7@ |
|
Term
Loan Agreement by and between OD1 JV Holdings LLC and Macquarie Equipment Capital Inc. |
| 99.1 |
|
Press Release dated November 18, 2026. |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document). |
*
Certain portions of the exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because they are both (i) not
material to investors and (ii) is the type that the registrant treats as private or confidential. The Company agrees to furnish supplementally
an unredacted copy of this exhibit and its materiality and privacy or confidentiality analyses to the SEC upon request.
**
The schedules to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby agrees to furnish
supplementally a copy of any omitted schedule to the SEC upon request.
@ To be filed by amendment to this Current
Report on Form 8-K.
SIGNATURE
Pursuant
to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
| Dated:
November 18, 2026 |
By:
|
/s/
Jerome Wong |
| |
Name: |
Jerome
Wong |
| |
Title: |
Chief
Financial Officer |
Exhibit 99.1
ChronoScale
Announces New Development Partnership to Accelerate AI Compute Capacity Deployment, Supported by a Significant Capital Raise
Initial deployment for a leading
frontier AI lab
The
initial deployment carries a total contract value of $7.5 billion over six years
| ● | Up
to $750 million financing with participation by four strategic investors, including among
others, Nutanix, Empery Digital Inc., and a storage infrastructure company |
| | | |
| ● | Financing
brings together blue chip participants across the AI infrastructure ecosystem |
MENLO
PARK, Calif., November 18, 2026 — ChronoScale Holdings Corporation (Nasdaq: CHRN) (“ChronoScale” or the
“Company”), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced
that it has entered into definitive agreements to form a 50/50 development partnership with STN, Inc. to develop its Odessa, Texas site and a $750 million financing
including strategic investors. The partnership’s site will house a large-scale AI infrastructure deployment with a leading frontier
AI lab. The agreement contemplates AI infrastructure capacity across three phases with the first phase ordered and
scheduled for deployment in the first half of calendar year 2027. GPU configurations vary by phase. On a blended basis across all three
phases, the agreement represents approximately $20.8 million of annual revenue per megawatt. Each of the Company and STN will contribute
$390 million in value to the partnership in exchange for a 50% interest, subject to HSR clearance.
A
substantial portion of the first phase is backstopped by credit support from an investment-grade technology company and
is expected to provide up to $7.5 billion in total contract value (“TCV”) to the partnership over six years.
“We
continue to see frontier AI moving beyond incremental compute expansion toward infrastructure commitments measured in hundreds of megawatts,”
said Cenly Chen, Chief Executive Officer of ChronoScale. “We believe delivering at this scale requires more than access to technology.
Capital, strategic partnerships, and operational capabilities are critical to bring complex deployments online in a reliable manner.
This new agreement and financing, along with the support of our key strategic investors represents to us the confidence placed in our
ability to execute and establish a strong foundation for ChronoScale’s continued growth.”
$750
Million Financing
The
financing consists of $250 million in equity and an up to $500 million convertible preferred facility. A portion of the common equity
will be initially issued pursuant to a note structure held by Applied Digital Corporation, subject to conversion into underlying shares
of common equity in Q4 2026. The convertible preferred facility is structured with an initial minimum conversion price of $12 per share
and may be drawn by the Company over a four-year period, subject to certain customary draw conditions for facilities of this type. Upon
closing, the Company expects to draw $10 million under the convertible preferred facility, with the remaining capacity
providing ChronoScale with additional financing to support future deployment requirements.
Four
strategic investors are participating in the financing: a leading frontier AI lab, Nutanix, Empery Digital Inc., and a storage
infrastructure company. The equity investments to be made by these blue chip partners, as well as other institutional investors,
collectively underscore, for us the strategic importance of ChronoScale bringing together the technology, capital and infrastructure
capabilities required to deliver AI compute at scale.
The
equity financing is intended to support ChronoScale’s phased infrastructure deployment strategy under the development
partnership, while the convertible preferred facility is intended to provide financial flexibility as the Company scales its operations
to meet accelerating customer demand.
Goldman
Sachs & Co. LLC is serving as exclusive capital markets advisor to ChronoScale and is acting as lead placement agent for the financing.
Northland Capital Markets is acting as co-placement agent for the financing. Lake Street Capital Markets and B. Riley Securities are
serving as senior financial advisors, and Lucid Capital Markets and Needham & Company are serving as financial advisors, to ChronoScale.
Development
Partnership
The
partnership will be a collaboration between the Company and STN, Inc., the initial developer of the data center campus located
in Odessa, Texas. The first 65 MW of the planned deployment of this campus is scheduled to be completed in accordance with the deployment
schedule. The Company has a right of first offer on the remaining 285 MW of capacity at the campus, to support the second and
third phases of the agreement, if those are ordered. The proceeds of the Company’s common equity financing will fund the initial
portion of its contribution only, with the balance to be funded from cash on hand, other existing sources of capital, and/or future project
financing. The Company will manage the partnership in cooperation with representatives from STN. The Company will initially be
entitled to 50% of the profits and losses from the partnership based on its initial common equity ownership. The closing of the partnership
and the financing are each expected to occur on November 18, 2026, subject to the satisfaction or waiver of the closing conditions.
Phased
Deployment and Long-Term Growth
ChronoScale
is building an end-to-end AI infrastructure ecosystem designed to bring together hyperscalers, storage innovators, hardware manufacturers,
and AI software companies. Through its expanding AI infrastructure footprint and strategic partnerships, the Company is focused on delivering
dedicated, production-scale AI environments which it believes are optimized for training, inference, and high-performance computing.
We
believe the development partnership marks another significant step in ChronoScale’s strategy to establish itself
as a global provider of large-scale AI infrastructure, supporting the rapidly expanding compute requirements of frontier AI developers
and enterprise customers.
About
ChronoScale
ChronoScale
(Nasdaq: CHRN) is an accelerated compute platform purpose-built to support demanding artificial intelligence workloads. Focused on large-scale
deployments, the platform delivers dedicated compute environments optimized for performance, consistency, and long-term operational execution,
with the ability to scale capacity alongside accelerating AI demand.
Forward-Looking
Statements
This
press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding: (i) the consummation and timing of the closings of the partnership and the financing; (ii)
the expected blended annual revenue per megawatt of $20.8 million, and the Company’s expected share; (iii) the expected
up to $7.5 billion TCV of the confirmed 65 MW first phase; (iv) potential customer orders for Phases 2 and 3 of the contemplated
350 MW deployment; (v) first-phase deployment in the first half of 2027 and later phases through 2028; (vi) the Company’s
right of first offer on the remaining 285 MW and potential development of and customer rights concerning the campus’s planned
capacity; (vii) partnership contributions, management and benefits; (viii) availability and intended use of financing,
including the convertible preferred facility; (ix) customer demand; and (x) strategic relationships. These statements use
words, and variations of words, such as “anticipate,” “believe,” “contemplate,” “could,”
“expect,” “intend,” “may,” “plan,” “potential,” “scheduled,”
and “will.”
These
statements reflect management’s current expectations and assumptions and are not guarantees. Actual results may differ materially
due to risks including: the risk that the closings of the partnership or the financing do not occur on the anticipated timeline or
at all; customer or credit support provider nonperformance; contract termination, amendment or nonrenewal; the customer having no
commitment to order Phases 2 or 3, without which the partnership’s total contract value will be substantially lower; development
beyond the confirmed 65 MW, including the remaining 285 MW and expansion, being subject to additional customer orders, exercise
of the Company’s right of first offer and agreement on terms, definitive agreements, necessary land, permits, power and interconnection
capacity, substantial additional financing on acceptable terms, and third-party cooperation; permitting and regulatory approvals, including
the permits that may be needed for all phases; construction, equipment, supply chain and deployment delays or cost overruns; power and
interconnection availability, cost and timing; funding requirements and preferred equity draw conditions; financing-related dilution;
performance of and relationships with STN, Inc. and other partners; competition and demand for AI infrastructure; and other risks described
in the Company’s most recent Form 10-K and subsequent Forms 10-Q filed with the SEC. No assurance can be given that additional
capacity will be ordered, developed or deployed on schedule or at all, or generate anticipated revenue or contract value.
Investors
should not place undue reliance on forward-looking statements, which speak only as of the date made. Except as required by law, the Company
undertakes no obligation to update these statements.
Investor
Relations & Media Contacts
Matt
Glover or Ralf Esper
Gateway Group, Inc.
(949) 574-3860
CHRN@gateway-grp.com